Through cbioportal analysis of how the genes were correlated with prognosis (Figure 5), we observed improved overall survival rate of ovarian cancer patients with CEP55 variation, with a statistically significant difference (p = 0.012). This evidence concerns the gene CEP55 and ovarian cancer.